Literature DB >> 29982268

Effects of copper and zinc on ischemic heart disease and myocardial infarction: a Mendelian randomization study.

Hanish P Kodali1, Brian T Pavilonis1, C Mary Schooling1,2.   

Abstract

Background: Despite great progress in prevention and control, ischemic heart disease (IHD) remains a leading cause of global morbidity and mortality. Diet plays a key role in IHD, but a comprehensive delineation of the role of dietary factors in IHD is not yet quite complete. Objective: The aim of this study was to test the long-standing hypothesis that copper is protective and zinc harmful in IHD. Design: We used separate-sample instrumental variable analysis with genetic instruments (Mendelian randomization). We obtained single nucleotide polymorphisms (SNPs) from a genome wide association study, strongly (P value < 5 × 10-8) and independently associated with erythrocyte copper and zinc. We applied these genetic predictors of copper and zinc to the largest, most extensively genotyped IHD case (n ≤ 76014)-control (n ≤ 264785) study, based largely on CARDIoGRAMplusC4D 1000 Genomes and the UK Biobank SOFT CAD, to obtain SNP-specific Wald estimates for the effects of copper and zinc on IHD, which were combined through the use of inverse variance weighting. Sensitivity analysis included use of the MR-Egger method, and reanalysis including SNPs independently associated with erythrocyte copper and zinc at P value < 5 × 10-6.
Results: Genetically instrumented copper was negatively associated with IHD (OR: 0.94; 95% CI: 0.90, 0.98). Genetically instrumented zinc was positively associated with IHD (OR: 1.06; 95% CI: 1.02, 1.11). Sensitivity analysis via MR-Egger gave no indication of unknown pleiotropy; less strongly associated SNPs gave similar results for copper.
Conclusion: Genetic validation of a long-standing hypothesis suggests that further investigation of the effects, particularly of copper, on IHD may provide a practical means of reducing the leading cause of mortality and morbidity.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29982268     DOI: 10.1093/ajcn/nqy129

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  12 in total

1.  Reduced Serum Zinc Ion Concentration Is Associated with Coronary Heart Disease.

Authors:  Heyu Meng; Yueying Wang; Fengfeng Zhou; Jianjun Ruan; Meiyu Duan; Xue Wang; Qiong Yu; Ping Yang; Weiwei Chen; Fanbo Meng
Journal:  Biol Trace Elem Res       Date:  2021-01-02       Impact factor: 3.738

2.  Causal Relationship of Genetically Predicted Serum Micronutrients Levels With Sarcopenia: A Mendelian Randomization Study.

Authors:  Tingting Sha; Wei Li; Hongyi He; Jing Wu; Yilun Wang; Hui Li
Journal:  Front Nutr       Date:  2022-06-22

3.  COMMD1 upregulation is involved in copper efflux from ischemic hearts.

Authors:  Chen Li; Tao Wang; Ying Xiao; Kui Li; Xia Meng; Y James Kang
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-06

4.  Ionomic profiling of pericardial fluid in ischemic heart disease.

Authors:  Noman Khan; Satwat Hashmi; Amna Jabbar Siddiqui; Sabiha Farooq; Shahid Ahmed Sami; Nageeb Basir; Syeda Saira Bokhari; Hasanat Sharif; Sanaullah Junejo; Syed Ghulam Musharraf
Journal:  RSC Adv       Date:  2020-10-02       Impact factor: 4.036

5.  Reproduction and longevity: A Mendelian randomization study of gonadotropin-releasing hormone and ischemic heart disease.

Authors:  C M Schooling; Jack C M Ng
Journal:  SSM Popul Health       Date:  2019-05-25

6.  Diet-Derived Circulating Antioxidants and Risk of Stroke: A Mendelian Randomization Study.

Authors:  Rujia Miao; Jing Li; Changjiang Meng; Yalan Li; Haibo Tang; Jie Wang; Peizhi Deng; Yao Lu
Journal:  Oxid Med Cell Longev       Date:  2022-01-17       Impact factor: 6.543

7.  Understanding of metals dysregulation in patients with systolic and diastolic dysfunction in ischemic heart disease.

Authors:  Noman Khan; Satwat Hashmi; Amna Jabbar Siddiqui; Sabiha Farooq; Shahid Ahmed Sami; Nageeb Basir; Syeda Saira Bokhari; Hasanat Sharif; Sanaullah Junejo; Hesham R El-Seedi; Syed Ghulam Musharraf
Journal:  Sci Rep       Date:  2020-08-18       Impact factor: 4.379

8.  The Causal Effects of Blood Iron and Copper on Lipid Metabolism Diseases: Evidence from Phenome-Wide Mendelian Randomization Study.

Authors:  Jingqi Zhou; Chang Liu; Michael Francis; Yitang Sun; Moon-Suhn Ryu; Arthur Grider; Kaixiong Ye
Journal:  Nutrients       Date:  2020-10-17       Impact factor: 5.717

9.  The Effect of Circulating Zinc, Selenium, Copper and Vitamin K1 on COVID-19 Outcomes: A Mendelian Randomization Study.

Authors:  Maria K Sobczyk; Tom R Gaunt
Journal:  Nutrients       Date:  2022-01-06       Impact factor: 6.706

10.  Blood copper and risk of cardiometabolic diseases: a Mendelian randomization study.

Authors:  Susanne Jäger; Maria Cabral; Johannes F Kopp; Per Hoffmann; Esther Ng; John B Whitfield; Andrew P Morris; Lars Lind; Tanja Schwerdtle; Matthias B Schulze
Journal:  Hum Mol Genet       Date:  2022-03-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.